NCT05825937

Brief Summary

The purpose of this study is to evaluate an alternative way of continuously measuring blood pressure in patients coming for complex surgery. The investigators will directly compare the speed of set up and accuracy of the new ClearSight monitor to those taken by the arterial line monitor, which is the current gold standard for recording blood pressure measurements.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

April 11, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 11, 2025

Status Verified

January 1, 2025

Enrollment Period

4.6 years

First QC Date

April 11, 2023

Last Update Submit

May 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP)

    compare differences in blood pressure parameters (SBP, DBP, MAP) collected by ClearSight system versus gold standard (radial arterial line)

    duration of surgery

Secondary Outcomes (1)

  • time to place instrument

    before surgery

Study Arms (2)

Elective Cardiac Surgery Patients

Patients having elective cardiac surgery, who have given written consent, will have the ClearSight device, along with the standard radial arterial line.

Device: ClearSight System

Elective Neurointerventional Surgery Patients

Patients having elective neurointerventional surgery, who have given written consent, will have the ClearSight device, along with the standard radial arterial line.

Device: ClearSight System

Interventions

Patients having either elective cardiac surgery or elective neurointerventional surgery will have blood pressure monitored by the ClearSight device, along with the standard of care radial arterial line, throughout their surgery. The arterial line will be placed on the radial artery contralateral to the upper arm blood pressure cuff. The ClearSight device will then be placed on the third finger of the hand ipsilateral to the radial arterial line.

Elective Cardiac Surgery PatientsElective Neurointerventional Surgery Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

These participants are receiving either elective cardiac surgery or elective neurointerventional surgery at the Royal University Hospital, Saskatoon.

You may qualify if:

  • written informed consent
  • undergoing elective cardiac surgery OR elective neurointerventional surgery (with standard arterial radial line for continuous blood pressure monitoring)

You may not qualify if:

  • undergoing emergent cardiac surgery OR emergent neurointerventional surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal University Hospital

Saskatoon, Saskatchewan, S7N 0W8, Canada

RECRUITING

Related Publications (3)

  • Rogge DE, Nicklas JY, Schon G, Grothe O, Haas SA, Reuter DA, Saugel B. Continuous Noninvasive Arterial Pressure Monitoring in Obese Patients During Bariatric Surgery: An Evaluation of the Vascular Unloading Technique (Clearsight system). Anesth Analg. 2019 Mar;128(3):477-483. doi: 10.1213/ANE.0000000000003943.

    PMID: 30649073BACKGROUND
  • Dahan A, Engberts DP, Niesters M. Arterial Line Placement: Safety First. Anesthesiology. 2016 Mar;124(3):528-9. doi: 10.1097/ALN.0000000000000968. No abstract available.

    PMID: 26606174BACKGROUND
  • Goncin U, Liu KK, Rawlyk B, Dalkilic S, Walker MEJ, Norton J, Hedlin P. Comparison of the ClearSight finger cuff monitor versus invasive arterial blood pressure measurement in elective cardiac surgery patients: a prospective observational study. Can J Anaesth. 2024 Nov;71(11):1495-1504. doi: 10.1007/s12630-024-02834-x. Epub 2024 Sep 24.

Study Officials

  • Peter Hedlin, PhD MD FRCPC

    University of Saskatchewan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peter Hedlin, PhD MD FRCPC

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Scientist, Assistant Professor

Study Record Dates

First Submitted

April 11, 2023

First Posted

April 24, 2023

Study Start

June 1, 2021

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 11, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations